(MENAFN- NewsBytes) Prime Minister Narendra Modi today addressed the nation at 10 am to speak on the country's vaccination drive. His address came a day after India achieved a milestone in its COVID-19 vaccination program, becoming only the second country after China to administer over a billion (100 crore) vaccine doses. Here are more details on this.
Quote PM calls the achievement 'a new chapter for the country'
"100 crore vaccine jabs is just not a number. It is the reflection of the capacity of this country, this is a new chapter for the country, a country that knows how to achieve huge targets," PM Modi said. He added that India ensured equality in the vaccination drive and there is "no VIP culture."
Details A journey from 'anxiety to assurance,' PM says
PM Modi has described India's vaccination drive as a journey from "anxiety to assurance," referring to the early snags such as low vaccine stocks. Yesterday, the PM had visited Ram Manohar Lohia (RML) Hospital in Delhi to interact with doctors and healthcare workers there. He also praised scientists in India and the collective spirit of Indians.
Data 75% of Indian adults have received a vaccine dose
According to the data from the government, 75% of over 94 crore adults in the country have received at least one dose and nearly 30% are fully vaccinated. States which have administered the highest number of vaccine doses are Uttar Pradesh, followed by Maharashtra, West Bengal, Gujarat, and Madhya Pradesh. China is the only other country to give out more than a billion doses.
Vaccines Which all vaccines are approved in India?
India's vaccination drive began in January this year with two vaccines - Covishield and COVAXIN. The country has since approved four more jabs, including the indigenous Zydus Cadila vaccine, Sputnik V, Moderna vaccine, and the Johnson & Johnson vaccine. India is yet to start vaccinating children against the coronavirus though the Zydus vaccine is approved for all people aged 12 and above.
MENAFN22102021000165011035ID1103018055
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.